Absolute risk differences (ARDs) for development of cutaneous T-cell lymphoma after dupilumab use
收藏Mendeley Data2026-04-09 收录
官方服务：
资源简介：
Absolute risk differences (ARDs) for development of cutaneous T-cell lymphoma after dupilumab use, ages 18-59 and Absolute risk differences (ARDs) for development of cutaneous T-cell lymphoma after dupilumab use, ages ≥60
